- support
- info@evidentic.com
- +49 (0) 30 959 99 8831
Retinal vein occlusion (RVO) occurs when the flow of blood from the retina is blocked and it is often caused by a blot clot blocking the retinal vein. The area that is not getting enough blood becomes then damaged.
Showing all 2 results
ProductBatch | Antigen | Molecular Class | Drug Brand | Product Concentration | CoA | Quantity per vial | Storage Temperature | Expiry Date | Price from | |
---|---|---|---|---|---|---|---|---|---|---|
PIGF , VEGF-A |
Fusion protein |
Eylea® |
40 mg/mL |
– |
0,8 mg |
-80°C |
11/2021 |
548,10 € |
||
PIGF , VEGF-A |
Fusion protein |
Eylea® |
40 mg/mL |
– |
0,8 mg |
-80°C |
02/2025 |
1.011,00 € |
Evidentic GmbH
Martin-Buber-Str. 10
14163 Berlin